← Eichor
Condition: Sickling Disorder Due To Hemoglobin S Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Sickling Disorder Due To Hemoglobin S

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease
NA · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07001631A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
NA · 1 location(s) · University of Florida · NCT04484272Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
NA · 1 location(s) · Children's National Research Institute · NCT05099874Stroke Prevention in Nigeria 2 Trial
Phase 4 · 2 location(s) · Vanderbilt University Medical Center · NCT06526117Ultrasound Acute Chest Syndrome Sickle Cell Disease
NA · 1 location(s) · Indiana University · NCT06880679AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Phase 2 · 1 location(s) · University of California, Davis · NCT06016634SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Phase 1 · 3 location(s) · St. Jude Children's Research Hospital · NCT06442761Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03685721Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
NA · 1 location(s) · Boston Children's Hospital · NCT06555939Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Phase 3 · 105 location(s) · Novo Nordisk A/S · NCT06609226Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT03279094Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07175051Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT05583721Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
NA · 5 location(s) · University of Pittsburgh · NCT04109820Blood Sampling for Research Related to Sickle Cell Disease
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00542230FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis
NA · 2 location(s) · Imam Abdulrahman Bin Faisal University · NCT07188766Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
Phase 1/Phase 2 · 6 location(s) · Kamau Therapeutics · NCT04819841Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Phase N/A · 1 location(s) · University Hospitals Cleveland Medical Center · NCT02824471Study of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA
Phase N/A · 1 location(s) · CHU de Reims · NCT06581900Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Phase 2 · 5 location(s) · CSL Behring · NCT07224360Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
NA · 14 location(s) · University of Pittsburgh · NCT06374238A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Phase 3 · 174 location(s) · Novo Nordisk A/S · NCT06612268Early Life Exposures Among Children With Sickle Cell Disease
NA · 1 location(s) · University of Alabama at Birmingham · NCT05377372RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
Phase N/A · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06213402Sickle-cell Disease Registry of the GPOH
Phase N/A · 1 location(s) · University Hospital Heidelberg · NCT03327428MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
NA · 2 location(s) · University of California, Irvine · NCT06853158Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Phase 1/Phase 2 · 4 location(s) · Washington University School of Medicine · NCT03128996
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.